UB-311
V203-AD-EXT
Phase 2 mab terminated
Quick answer
UB-311 for Alzheimer's Disease is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 3 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Alzheimer's Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated